Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease
出版年份 2022 全文链接
标题
Dapagliflozin reduces pulmonary vascular damage and susceptibility to atrial fibrillation in right heart disease
作者
关键词
-
出版物
ESC Heart Failure
Volume 10, Issue 1, Pages 578-593
出版商
Wiley
发表日期
2022-11-12
DOI
10.1002/ehf2.14169
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and safety of sodium-glucose cotransporter 2 inhibitors initiation in patients with acute heart failure, with and without type 2 diabetes: a systematic review and meta-analysis
- (2022) Husam M. Salah et al. Cardiovascular Diabetology
- Dapagliflozin effect on heart failure with prevalent or new‐onset atrial fibrillation
- (2022) Vicente Artola Arita et al. EUROPEAN JOURNAL OF HEART FAILURE
- Epicardial adipose tissue in contemporary cardiology
- (2022) Gianluca Iacobellis Nature Reviews Cardiology
- NLRP3 inflammasome is a key driver of obesity-induced atrial arrhythmias
- (2021) Larry Scott Jr et al. CARDIOVASCULAR RESEARCH
- Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances
- (2021) Bradley A Maron et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Sodium-glucose cotransporter 2 inhibitors (SGLT2i) and cardiac arrhythmias: a systematic review and meta-analysis
- (2021) Hang-Long Li et al. Cardiovascular Diabetology
- Dapagliflozin and Recurrent Heart Failure Hospitalizations in Heart Failure With Reduced Ejection Fraction: An Analysis of DAPA-HF
- (2021) Pardeep S. Jhund et al. CIRCULATION
- Association of SGLT2 inhibitors with arrhythmias and sudden cardiac death in patients with type 2 diabetes or heart failure: A meta-analysis of 34 randomized controlled trials
- (2021) Gilson C. Fernandes et al. HEART RHYTHM
- Targeting of Potassium Channels in Cardiac Arrhythmias
- (2021) Shira Burg et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- SGLT2 inhibitors: the statins of the 21st century
- (2021) Eugene Braunwald EUROPEAN HEART JOURNAL
- The physiologic basis of pulmonary arterial hypertension
- (2021) Robert Naeije et al. EUROPEAN RESPIRATORY JOURNAL
- Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial
- (2021) Subodh Verma et al. Lancet Diabetes & Endocrinology
- CCS/CHFS Heart Failure Guidelines: Clinical Trial Update on Functional Mitral Regurgitation, SGLT2 Inhibitors, ARNI in HFpEF, and Tafamidis in Amyloidosis
- (2020) Eileen O’Meara et al. CANADIAN JOURNAL OF CARDIOLOGY
- Systemic Consequences of Pulmonary Hypertension and Right-Sided Heart Failure
- (2020) Stephan Rosenkranz et al. CIRCULATION
- Correlation between Doppler echocardiography and right heart catheterization assessment of systolic pulmonary artery pressure in patients with severe aortic stenosis
- (2020) Jury Schewel et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- M2 macrophage-derived exosomes carry microRNA-148a to alleviate myocardial ischemia/reperfusion injury via inhibiting TXNIP and the TLR4/NF-κB/NLRP3 inflammasome signaling pathway
- (2020) Yuxiang Dai et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Challenges in atrial fibrillation: detection, alert systems, fibrosis, and infection
- (2020) Thomas F Lüscher EUROPEAN HEART JOURNAL
- Molecular Basis of Atrial Fibrillation Pathophysiology and Therapy
- (2020) Stanley Nattel et al. CIRCULATION RESEARCH
- Inflammasomes and Proteostasis Novel Molecular Mechanisms Associated With Atrial Fibrillation
- (2020) Na Li et al. CIRCULATION RESEARCH
- Atrial Myocyte NLRP3/CaMKII Nexus Forms a Substrate for Post-Operative Atrial Fibrillation
- (2020) Jordi Heijman et al. CIRCULATION RESEARCH
- Omeprazole attenuates cisplatin-induced kidney injury through suppression of the TLR4/NF-κB/NLRP3 signaling pathway
- (2020) Huan Gao et al. TOXICOLOGY
- Efficacy of Dapagliflozin on Renal Function and Outcomes in Patients with Heart Failure with Reduced Ejection Fraction: Results of DAPA-HF
- (2020) Pardeep S. Jhund et al. CIRCULATION
- Sodium‐glucose co‐transporter‐2 inhibitors and atrial fibrillation in the cardiovascular and renal outcome trials
- (2020) Victor Okunrintemi et al. DIABETES OBESITY & METABOLISM
- MG53, a Novel Regulator of KChIP2 and I to,f, Plays a Critical Role in Electrophysiological Remodeling in Cardiac Hypertrophy
- (2019) Wenjuan Liu et al. CIRCULATION
- Immunotherapy of Endothelin-1 Receptor Type A for Pulmonary Arterial Hypertension
- (2019) Yong Dai et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Dapagliflozin And Prevention of Adverse‐outcomes in Heart Failure (DAPA‐HF) trial: baseline characteristics
- (2019) John J.V. McMurray et al. EUROPEAN JOURNAL OF HEART FAILURE
- Disease–treatment interactions in the management of patients with obesity and diabetes who have atrial fibrillation: the potential mediating influence of epicardial adipose tissue
- (2019) Milton Packer Cardiovascular Diabetology
- Right Atrial Mechanisms of Atrial Fibrillation in a Rat Model of Right Heart Disease
- (2019) Roddy Hiram et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effects of Dapagliflozin on Symptoms, Function and Quality of Life in Patients with Heart Failure and Reduced Ejection Fraction: Results from the DAPA-HF Trial
- (2019) Mikhail N. Kosiborod et al. CIRCULATION
- Efficacy and Safety of Dapagliflozin in Heart Failure With Reduced Ejection Fraction According to Age: Insights From DAPA-HF
- (2019) Felipe A. Martinez et al. CIRCULATION
- Enhanced Cardiomyocyte NLRP3 Inflammasome Signaling Promotes Atrial Fibrillation
- (2018) Chunxia Yao et al. CIRCULATION
- Arrhythmias in adult patients with congenital heart disease and pulmonary arterial hypertension
- (2018) Maria Drakopoulou et al. HEART
- Prolonged corrected QT interval in predicting atrial fibrillation: A systematic review and meta-analysis
- (2018) Nixiao Zhang et al. PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY
- MD1 Deficiency Promotes Infiammatory Atrial Remodeling Induced by High-fat Diet
- (2018) Wei Shuai et al. CANADIAN JOURNAL OF CARDIOLOGY
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Electrocardiographic intervals associated with incident atrial fibrillation: Dissecting the QT interval
- (2017) Jason D. Roberts et al. HEART RHYTHM
- Chronic obstructive pulmonary disease and atrial fibrillation: An unknown relationship
- (2017) Christos A. Goudis Journal of Cardiology
- Right-to-left frequency gradient during atrial fibrillation initiated by right atrial ectopies and its augmentation by adenosine triphosphate: Implications of right atrial fibrillation
- (2016) Hideyuki Hasebe et al. HEART RHYTHM
- Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice
- (2015) Fadila Telarevic Cero et al. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY
- Correlation between Pulmonary Artery Pressure Measured by Echocardiography and Right Heart Catheterization in Patients with Rheumatic Mitral Valve Stenosis (A Prospective Study)
- (2015) Bahram Sohrabi et al. ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacodynamics, Efficacy and Safety of Sodium–Glucose Co-Transporter Type 2 (SGLT2) Inhibitors for the Treatment of Type 2 Diabetes Mellitus
- (2014) André J. Scheen DRUGS
- Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes
- (2014) David Z.I. Cherney et al. KIDNEY INTERNATIONAL
- Reliability of Noninvasive Assessment of Systolic Pulmonary Artery Pressure by Doppler Echocardiography Compared to Right Heart Catheterization: Analysis in a Large Patient Population
- (2014) Sebastian Greiner et al. Journal of the American Heart Association
- Inflammasomes and Their Roles in Health and Disease
- (2012) Mohamed Lamkanfi et al. Annual Review of Cell and Developmental Biology
- Arrhythmias in Pulmonary Arterial Hypertension
- (2012) Archana Rajdev et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Repolarization Alternans Reveals Vulnerability to Human Atrial Fibrillation
- (2011) Sanjiv M. Narayan et al. CIRCULATION
- Left Atrial Epicardial Adiposity and Atrial Fibrillation
- (2010) Omar Batal et al. Circulation-Arrhythmia and Electrophysiology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More